{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:07:20Z","timestamp":1794863240158,"version":"4.9.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Postoperative residual neuromuscular blockade (PRNB) is defined as an adductor pollicis train-of-four ratio (TOFR) &lt;0.9. It is a common postoperative complication when nondepolarizing muscle relaxants are either not reversed or reversed with neostigmine. PRNB has been reported in 25% to 58% of patients who receive intermediate-acting nondepolarizing muscle relaxants, and it is associated with increased morbidity and decreased patient satisfaction. We conducted a prospective descriptive cohort study during the implementation of a practice guideline that included the selective use of sugammadex or neostigmine. The primary study aim of this pragmatic study was to estimate the incidence of PRNB at arrival to the postanesthesia care unit (PACU) when the practice guideline is followed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We enrolled patients undergoing orthopedic or abdominal surgery requiring neuromuscular blockade. Rocuronium administration was guided by surgical requirements and based on ideal body weight, with dose reductions for women and\/or age &gt;55 years. Only qualitative monitoring was available to the anesthesia providers, and selection of sugammadex or neostigmine was guided by tactile assessments of the response to train-of-four (TOF) stimulation by a peripheral nerve stimulator. Neostigmine was administered if no fade was detected in the TOF response at the thumb. Deeper blocks were reversed with sugammadex. The prespecified primary and secondary end points were the incidence of PRNB at arrival to the PACU, defined as a normalized TOFR (nTOFR) &lt; 0.9, and severe PRNB, defined as nTOFR &lt;0.7 on arrival to the PACU. Anesthesia providers were blinded to all quantitative measurements made by research staff.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Analysis included 163 patients, and 145 underwent orthopedic and 18 abdominal surgeries. Of the 163 patients, 92 (56%) were reversed with neostigmine and 71 (44%) with sugammadex. The overall incidence of PRNB at PACU arrival was 5 of 163 or 3% (95% confidence interval [CI], 1\u20137). The incidence of severe PRNB in PACU was 1% (95% CI, 0\u20134). Three of the 5 subjects with PRNB had TOFR &lt;0.4 at time of reversal but were given neostigmine since anesthesia providers detected no fade by qualitative assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The use of a protocol that specifies rocuronium dosing and selective use of sugammadex versus neostigmine based on qualitative assessment of TOF count and fade allowed us to achieve an incidence of PRNB of 3% (95% CI, 1\u20137) at PACU arrival. Quantitative monitoring may be needed to further reduce this incidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006510","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T15:02:55Z","timestamp":1684508575000},"page":"1143-1153","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of a Protocol for the Management of Maintenance and Reversal of Rocuronium Block Using Neostigmine or Sugammadex"],"prefix":"10.1213","volume":"136","author":[{"given":"Stephan R.","family":"Thilen","sequence":"first","affiliation":[{"name":"Anesthesiology and Pain Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinny","family":"Liang","sequence":"additional","affiliation":[{"name":"Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy N.","family":"Kruse","sequence":"additional","affiliation":[{"name":"Anesthesiology and Pain Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Cain","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam M.","family":"Treggiari","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Duke University, Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay M.","family":"Bhananker","sequence":"additional","affiliation":[{"name":"Anesthesiology and Pain Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bja\/ael386","article-title":"Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis.","volume":"98","author":"Naguib","year":"2007","journal-title":"Br J Anaesth"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1213\/ANE.0000000000004028","article-title":"The effects of postoperative residual neuromuscular blockade on hospital costs and intensive care unit admission: a population-based cohort study.","volume":"128","author":"Grabitz","year":"2019","journal-title":"Anesth Analg"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/ALN.0b013e3181cded07","article-title":"Residual paralysis after emergence from anesthesia.","volume":"112","author":"Plaud","year":"2010","journal-title":"Anesthesiology"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/ALN.0b013e3182342840","article-title":"Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period.","volume":"115","author":"Murphy","year":"2011","journal-title":"Anesthesiology"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1213\/ANE.0000000000002670","article-title":"Consensus statement on perioperative use of neuromuscular monitoring.","volume":"127","author":"Naguib","year":"2018","journal-title":"Anesth Analg"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/oxfordjournals.bja.a013428","article-title":"Postoperative residual curarization and evidence-based anaesthesia.","volume":"84","author":"Viby-Mogensen","year":"2000","journal-title":"Br J Anaesth"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1213\/ANE.0b013e3181c07428","article-title":"A survey of current management of neuromuscular block in the United States and Europe.","volume":"111","author":"Naguib","year":"2010","journal-title":"Anesth Analg"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1213\/ANE.0000000000003714","article-title":"Anesthesiologists\u2019 overconfidence in their perceived knowledge of neuromuscular monitoring and its relevance to all aspects of medical practice: an international survey.","volume":"128","author":"Naguib","year":"2019","journal-title":"Anesth Analg"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"47","DOI":"10.17085\/apm.2018.13.1.47","article-title":"A survey of current concepts and practices related to use of neuromuscular blockers with antagonists and neuromuscular monitoring among Korean anesthesiologists.","volume":"13","author":"Choi","year":"2018","journal-title":"Anesth Pain Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0310057X21995498","article-title":"A survey of current management of neuromuscular block and reversal in Australia and New Zealand.","volume":"49","author":"Olesnicky","year":"2021","journal-title":"Anaesth Intensive Care"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"591","DOI":"10.11622\/smedj.2019118","article-title":"Survey of neuromuscular monitoring and assessment of postoperative residual neuromuscular block in a postoperative anaesthetic care unit.","volume":"61","author":"Lin","year":"2020","journal-title":"Singapore Med J"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jep.13151","article-title":"Sugammadex in Ontario hospitals: access and institutional policies.","volume":"26","author":"Cohen","year":"2020","journal-title":"J Eval Clin Pract"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bja\/aex171","article-title":"Using a worldwide in-app survey to explore sugammadex usage patterns: a prospective observational study.","volume":"119","author":"O\u2019Reilly-Shah","year":"2017","journal-title":"Br J Anaesth"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/EJA.0000000000001769","article-title":"Peri-operative management of neuromuscular blockade: a guideline from the European Society of Anaesthesiology and Intensive Care.","volume":"40","author":"Fuchs-Buder","year":"2023","journal-title":"Eur J Anaesthesiol"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","article-title":"2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: a report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade.","volume":"2023","author":"Thilen","year":"2023","journal-title":"Anesthesiology"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/2229-5151.170846","article-title":"Postoperative sciatic and femoral or saphenous nerve blockade for lower extremity surgery in anesthetized adults.","volume":"5","author":"Lollo","year":"2015","journal-title":"Int J Crit Illn Inj Sci"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/ALN.0b013e3181c53863","article-title":"Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.","volume":"112","author":"Fuchs-Buder","year":"2010","journal-title":"Anesthesiology"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00000542-200201000-00013","article-title":"Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block.","volume":"96","author":"Kirkegaard","year":"2002","journal-title":"Anesthesiology"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/bja\/aev437","article-title":"Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)\u2020,.","volume":"116","author":"Kaufhold","year":"2016","journal-title":"Br J Anaesth"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00000542-198510000-00015","article-title":"Tactile and visual evaluation of the response to train-of-four nerve stimulation.","volume":"63","author":"Viby-Mogensen","year":"1985","journal-title":"Anesthesiology"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1213\/ane.0b013e3181b0826a","article-title":"Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?","volume":"109","author":"Meyhoff","year":"2009","journal-title":"Anesth Analg"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/ALN.0b013e31826f8fdd","article-title":"Intraoperative neuromuscular monitoring site and residual paralysis.","volume":"117","author":"Thilen","year":"2012","journal-title":"Anesthesiology"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1213\/00000539-199709000-00033","article-title":"Dose-response and time course of effect of rocuronium in male and female anesthetized patients.","volume":"85","author":"Xue","year":"1997","journal-title":"Anesth Analg"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5507\/bp.2011.050","article-title":"Influence of age and gender on the pharmacodynamic parameters of rocuronium during total intravenous anesthesia.","volume":"155","author":"Adamus","year":"2011","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/ALN.0000000000000865","article-title":"Residual neuromuscular block in the elderly: incidence and clinical implications.","volume":"123","author":"Murphy","year":"2015","journal-title":"Anesthesiology"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1213\/ANE.0000000000000471","article-title":"Laparoscopic surgery and muscle relaxants: is deep block helpful?","volume":"120","author":"Kopman","year":"2015","journal-title":"Anesth Analg"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ALN.0b013e31826f9143","article-title":"Neuromuscular monitoring: more than meets the eye.","volume":"117","author":"Donati","year":"2012","journal-title":"Anesthesiology"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/bja\/aei273","article-title":"Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block.","volume":"96","author":"Suzuki","year":"2006","journal-title":"Br J Anaesth"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/anae.15009","article-title":"Progress towards a standard of quantitative twitch monitoring.","volume":"75","author":"Bowdle","year":"2020","journal-title":"Anaesthesia"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bja.2020.05.063","article-title":"Forty years of neuromuscular monitoring and postoperative residual curarisation: a meta-analysis and evaluation of confidence in network meta-analysis.","volume":"125","author":"Carvalho","year":"2020","journal-title":"Br J Anaesth"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0310057X1304100316","article-title":"A survey of the management of neuromuscular blockade monitoring in Australia and New Zealand.","volume":"41","author":"Phillips","year":"2013","journal-title":"Anaesth Intensive Care"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1399-6576.2007.01352.x","article-title":"Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.","volume":"51","author":"Fuchs-Buder","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3181f4182a","article-title":"Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.","volume":"113","author":"Schaller","year":"2010","journal-title":"Anesthesiology"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000542-197407000-00005","article-title":"Comparative times to peak effect and durations of action of neostigmine and pyridostigmine.","volume":"41","author":"Miller","year":"1974","journal-title":"Anesthesiology"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/EJA.0b013e328345cd11","article-title":"The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial.","volume":"28","author":"Sauer","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1007\/BF03019212","article-title":"Neuromuscular monitoring: useless, optional or mandatory?","volume":"45","author":"Donati","year":"1998","journal-title":"Can J Anaesth"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bja.2018.03.029","article-title":"Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.","volume":"121","author":"Thilen","year":"2018","journal-title":"Br J Anaesth"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/ALN.0000000000002400","article-title":"Comparison of the TOFscan and the TOF-Watch SX during recovery of neuromuscular function.","volume":"129","author":"Murphy","year":"2018","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:32:35Z","timestamp":1786113155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006510","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}